Bend, OR, June 07, 2017 -- Signal Bay, Inc. (“Signal Bay”) (OTCQB:SGBY), a provider of quality control testing and advisory services to the regulated cannabis industry, is issuing this press release to correct an error in the press release issued on May 22, 2017. Revenues for the quarter ended March 31, 2017 increased by 25% from $668,456 for the quarter ended December 31, 2016 to $832,723 for the quarter ended March 31, 2017, rather than 125% as previously reported.
About Signal Bay
Signal Bay, Inc. (the “Company”) is an Oregon-based Bio-Tech company. Through its three subsidiaries: EVIO Labs, Signal Bay Research and Signal Bay Services; the Company provides analytical testing services, management advisory services and scientific research to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a team of professional scientists to ensure the safety and quality of the nation's cannabis supply. Learn more at http://www.SignalBay.com or the Company can be reached directly @ 1-888-544-EVIO.
Safe Harbor Statement
Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or www.signalbay.com
Investor Relations: [email protected]


San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Meta Is Building an AI Version of Mark Zuckerberg to Interact With Employees
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG 



